Asston Pharmaceuticals Share Price Today | Stock Price & Asston Pharmaceuticals Share Screener

Track the current stock price of Asston Pharmaceuticals with an interactive chart. Analyse APL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Asston Pharmaceuticals stock quote in one place.

Screen Asston Pharmaceuticals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for APL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Capital Goods sector and the Other Electrical Equipment industry, and it trades under ISIN INE0SJX01015.

Classification

Identifiers and Leadership

Screen APL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹28, up from ₹20 in 2024.

Latest statistics put total assets at ₹28 and shareholder funds at ₹11, with a leverage ratio of 0.77.

Screen Asston Pharmaceuticals income statement and profit fundamentals. Analyze APL quarterly results. Asston Pharmaceuticals reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹26 and net profit of ₹4.

Screen APL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹0.

Over the same period, investing activities provided ₹1 and financing activities used ₹1.

See Asston Pharmaceuticals shareholding pattern with promoter, FII, and DII holdings. Check Asston Pharmaceuticals promoter holding and ownership changes for APL on TickJournal, and see how institutional stock price moves affect the market.

In 2025-Sept, promoters held 50.66%, foreign institutions 6.04%, domestic institutions 0.00% and the public 37.06%, spread across 751 shareholders.

The shareholder count was 751 in 2025-Sept, compared with 128 in 2025-Jul.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Asston Pharmaceuticals. Asston Pharmaceuticals dividend yield can be compared with peers and other stocks in the market.

See which indices include Asston Pharmaceuticals stock. Check APL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Get Asston Pharmaceuticals corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Asston Pharmaceuticals stock events that may affect APL share price, along with derivatives, futures and options activity and sector gainers.

2 corporate actions are listed, the most recent entry being Annual General Meeting dated .

Screen APL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Capital Goods sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen APL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated March 2, 2026.

The next most recent announcements are dated March 2, 2026 and February 7, 2026.

Key statistics were last updated on October 6, 2026. This page covers 4 balance sheet periods, 5 income statement periods, 4 cash flow years and 4 shareholding periods. Information is provided for research and is not investment advice.